Pseudohypoparathyroidism: a missed window of treatment opportunity?

Acta Neurol Belg. 2021 Feb;121(1):259-260. doi: 10.1007/s13760-019-01268-3. Epub 2020 Jan 1.

Authors

K David¹, K Stinkens², B Decallonne³

Affiliations

¹ Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium. karel.david@kuleuven.be.
² Department of Endocrinology, ZOL, Genk, Belgium.
³ Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.

PMID: 31893352
DOI: 10.1007/s13760-019-01268-3

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Calcium / administration & dosage
Delayed Diagnosis* / adverse effects
Female
Humans
Pseudohypoparathyroidism / blood
Pseudohypoparathyroidism / diagnostic imaging*
Pseudohypoparathyroidism / drug therapy*
Time-to-Treatment*
Treatment Outcome
Vitamin D / administration & dosage

Substances

Vitamin D
Calcium